Genetic Technologies (GENE) Institutional Ownership $0.76 0.00 (0.00%) As of 03/27/2025 Add Compare Share Share Ownership Stock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Genetic Technologies (NASDAQ:GENE)CurrentInstitutional OwnershipPercentage0.63%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$236.30KNumber ofInstitutional Sellers(last 12 months)0 Get GENE Insider Trade Alerts Want to know when executives and insiders are buying or selling Genetic Technologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GENE Institutional Buying and Selling by Quarter Remove Ads Genetic Technologies Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024 Armistice Capital LLC140,000$210K0.0%N/A3.177% 5/1/2024 BNP Paribas Financial Markets9,100$26K0.0%N/A0.236% 11/7/2023 Scarborough Advisors LLC548,372$417K0.0%+5,054.8%2.850% 3/6/2023 OLD Mission Capital LLC70,241$65K0.0%+109.7%0.365% 11/22/2022 Continental Investors Services Inc.32,000$47K0.0%N/A0.208% 11/14/2022 OLD Mission Capital LLC33,499$39K0.0%N/A0.218% 8/13/2021 Jump Financial LLC10,657$45K0.0%N/A0.069% 8/11/2021 Susquehanna Fundamental Investments LLC36,172$154K0.0%-44.0%0.235% 5/17/2021 Hennion & Walsh Asset Management Inc.10,072$42K0.0%N/A0.067% 5/17/2021 Goldman Sachs Group Inc.21,602$90K0.0%N/A0.144% 2/12/2021Credit Suisse AG20,836$75K0.0%N/A0.139% (Data available from 1/1/2016 forward)Remove Ads GENE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GENE shares? During the previous two years, the following institutional investors and hedge funds held shares of Genetic Technologies shares: Scarborough Advisors LLC ($417K), and Armistice Capital LLC ($210K), BNP Paribas Financial Markets ($26K).Learn more on GENE's institutional investors. What percentage of Genetic Technologies stock is owned by institutional investors? 0.63% of Genetic Technologies stock is owned by institutional investors. Learn more on GENE's institutional investor holdings. Which institutional investors have been buying Genetic Technologies stock? The following institutional investors have purchased Genetic Technologies stock in the last 24 months: Scarborough Advisors LLC ($537.73K), Armistice Capital LLC ($140K), and BNP Paribas Financial Markets ($9.10K). How much institutional buying is happening at Genetic Technologies? Institutional investors have bought a total of 686,834 shares in the last 24 months. This purchase volume represents approximately $2.29M in transactions. Related Companies HCWB Major Shareholders IPA Major Shareholders CTXR Major Shareholders ATHA Major Shareholders GOVX Major Shareholders BMRA Major Shareholders NERV Major Shareholders FLGC Major Shareholders CING Major Shareholders APRE Major Shareholders This page (NASDAQ:GENE) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genetic Technologies Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Genetic Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
